GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hangzhou Biotest Biotech Co Ltd (SHSE:688767) » Definitions » Other Income (Expense)

Hangzhou Biotest Biotech Co (SHSE:688767) Other Income (Expense) : ¥-54.2 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Biotest Biotech Co Other Income (Expense)?

Hangzhou Biotest Biotech Co's other income expense for the Hangzhou Biotest Biotech Co's pretax income for the three months ended in Sep. 2024 was ¥-4.4 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-54.2 Mil.

Hangzhou Biotest Biotech Co Other Income (Expense) Historical Data

The historical data trend for Hangzhou Biotest Biotech Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Biotest Biotech Co Other Income (Expense) Chart

Hangzhou Biotest Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial -1.72 -24.13 -27.23 45.90 -43.33

Hangzhou Biotest Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.95 -48.53 -0.49 -0.80 -4.44

Hangzhou Biotest Biotech Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-54.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Biotest Biotech Co  (SHSE:688767) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Hangzhou Biotest Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hangzhou Biotest Biotech Co Ltd (SHSE:688767) » Definitions » Other Income (Expense)
Comparable Companies
SHSE:688253 SZSE:301258 SHSE:688098 SHSE:688399 SHSE:688265 SZSE:300966 SZSE:000518 SHSE:688426 SZSE:002898 SHSE:688089 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 17, Futai Road, Zhongtai Street, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311121
Website
http://www.biotests.com.cn
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.

Hangzhou Biotest Biotech Co Headlines

No Headlines